3-Methyl-2-oxovaleric Acid is an abnormal metabolite that arises from the incomplete breakdown of branched-chain amino acids. It is a neurotoxin, an acidogen, and a metabotoxin.
Chronically high levels of 3-Methyl-2-oxovaleric Acid is associated with maple syrup urine disease, which is a metabolic disorder caused by a deficiency of the branched-chain alpha—keto acid dehydrogenase complex, leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids).
Dietary supplements containing thiamine may help reducing elevated levels of 3-Methyl-2-oxovaleric Acid.
Understand and improve your laboratory results with our health dashboard.
Upload your lab reports and get interpretation today.
Our technology helps to understand, combine, track, organize, and act on your medical lab test results.
A moderate increase of branched-chain amino acid metabolites in urine may result from lactic acidosis, episodic ketosis, or deficiencies of the vitamins, thiamine or lipoic acid.
A significant increase of branched-chain amino acid metabolites is associated with the genetic disorders maple syrup urine disease (=MSUD) and pyruvate dehydrogenase deficiency.
MSUD is a metabolic disorder caused by a deficiency of the branched-chain alpha-keto acid dehydrogenase complex (BCKDC), leading to a buildup of the branched-chain amino acids (leucine, isoleucine, and valine) and their toxic by-products (ketoacids) in the blood and urine. The symptoms of MSUD often show in infancy and lead to severe brain damage if untreated. MSUD may also present later depending on the severity of the disease. If left untreated in older individuals, during times of metabolic crisis, symptoms of the condition include uncharacteristically inappropriate, extreme, or erratic behaviour and moods, hallucinations, anorexia, weight loss, anemia, diarrhea, vomiting, dehydration, lethargy, oscillating hypertonia and hypotonia, ataxia, seizures, hypoglycemia, ketoacidosis, opisthotonus, pancreatitis, rapid neurological decline, and coma. In maple syrup urine disease, the brain concentration of branched-chain keto acids can increase 10- to 20-fold. This leads to a depletion of glutamate and a consequent reduction in the concentration of brain glutamine, aspartate, alanine, and other amino acids. The result is a compromise of energy metabolism because of a failure of the malate-aspartate shuttle and a diminished rate of protein synthesis.
Potential treatment options:
Patients with slight to moderate elevations may use dietary supplements containing thiamine to improve clinical symptoms.
Interpret Your Lab Results
Upload your lab report and we’ll interpret and provide you with recomendations today.Get Started
Get Started With Our Personal Plan
Are You a Health Professional?
Get started with our professional plan
Welcome to Healthmatters Pro.
Save time on interpreting lab results with the largest database of biomarkers online. In-depth research on any test at your fingertips, all stored and tracked in one place. Learn more
for health professionals
$45 per month
2-Hydroxyhippuric acid, 2-Hydroxyisocaproic acid, 3-Methyl-2-oxovaleric acid, Arabinose, Ascorbic acid (Vitamin C), Citric acid, Furancarbonylglycine, GABA, Glyceric acid, HVA/DOPAC, HVA/VMA Ratio, Lactic acid, Methylmalonic acid (Vitamin B12), Norepinephrine/Epinephrine, Quinolinic acid/5-HIAA, Quinolinic acid/5-HIAA Ratio, Suberic acid